ConductScience.org, home

Trial · NCT00958477

Results by group461

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Subjects With Dose Limiting Toxicity (DLT)EMD 525797 250 mg0subjects
Number of Subjects With Dose Limiting Toxicity (DLT)EMD 525797 500 mg0subjects
Number of Subjects With Dose Limiting Toxicity (DLT)EMD 525797 1000 mg0subjects
Number of Subjects With Dose Limiting Toxicity (DLT)EMD 525797 1500 mg0subjects
Number of Subjects With Treatment Emergent Adverse Events (TEAEs), Serious TEAEs and Related TEAEsEMD 525797 250 mgTEAEs8Subjects
Number of Subjects With Treatment Emergent Adverse Events (TEAEs), Serious TEAEs and Related TEAEsEMD 525797 500 mgTEAEs6Subjects
Number of Subjects With Treatment Emergent Adverse Events (TEAEs), Serious TEAEs and Related TEAEsEMD 525797 1000 mgTEAEs6Subjects
Number of Subjects With Treatment Emergent Adverse Events (TEAEs), Serious TEAEs and Related TEAEsEMD 525797 1500 mgTEAEs6Subjects
Number of Subjects With Treatment Emergent Adverse Events (TEAEs), Serious TEAEs and Related TEAEsEMD 525797 250 mgSerious TEAEs5Subjects
Number of Subjects With Treatment Emergent Adverse Events (TEAEs), Serious TEAEs and Related TEAEsEMD 525797 500 mgSerious TEAEs1Subjects
Number of Subjects With Treatment Emergent Adverse Events (TEAEs), Serious TEAEs and Related TEAEsEMD 525797 1000 mgSerious TEAEs4Subjects
Number of Subjects With Treatment Emergent Adverse Events (TEAEs), Serious TEAEs and Related TEAEsEMD 525797 1500 mgSerious TEAEs3Subjects
Number of Subjects With Treatment Emergent Adverse Events (TEAEs), Serious TEAEs and Related TEAEsEMD 525797 250 mgRelated TEAEs2Subjects
Number of Subjects With Treatment Emergent Adverse Events (TEAEs), Serious TEAEs and Related TEAEsEMD 525797 500 mgRelated TEAEs4Subjects
Number of Subjects With Treatment Emergent Adverse Events (TEAEs), Serious TEAEs and Related TEAEsEMD 525797 1000 mgRelated TEAEs2Subjects
Number of Subjects With Treatment Emergent Adverse Events (TEAEs), Serious TEAEs and Related TEAEsEMD 525797 1500 mgRelated TEAEs3Subjects
Observed Maximum Serum Concentration (Cmax) of EMD 525797 After First InfusionEMD 525797 250 mg52.9Geometric Coefficient of Variation 15.3microgram per milliliter (mcg/mL)
Observed Maximum Serum Concentration (Cmax) of EMD 525797 After First InfusionEMD 525797 500 mg115.5Geometric Coefficient of Variation 20.1microgram per milliliter (mcg/mL)
Observed Maximum Serum Concentration (Cmax) of EMD 525797 After First InfusionEMD 525797 1000 mg298.0Geometric Coefficient of Variation 10.8microgram per milliliter (mcg/mL)
Observed Maximum Serum Concentration (Cmax) of EMD 525797 After First InfusionEMD 525797 1500 mg368.9Geometric Coefficient of Variation 26.7microgram per milliliter (mcg/mL)

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00958477/results